Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics
- PMID: 28682309
- DOI: 10.1038/gim.2017.84
Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics
Erratum in
-
ERRATUM: Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.Genet Med. 2018 Feb;20(2):282. doi: 10.1038/gim.2017.201. Epub 2017 Dec 14. Genet Med. 2018. PMID: 29240078
-
Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics.Genet Med. 2023 Jan;25(1):164-165. doi: 10.1016/j.gim.2022.11.014. Genet Med. 2023. PMID: 36609149 No abstract available.
Abstract
Disclaimer: These ACMG Standards and Guidelines are intended as an educational resource for clinical laboratory geneticists to help them provide quality clinical laboratory genetic services. Adherence to these Standards and Guidelines is voluntary and does not necessarily assure a successful medical outcome. These Standards and Guidelines should not be considered inclusive of all proper procedures and tests or exclusive of others that are reasonably directed to obtaining the same results. In determining the propriety of any specific procedure or test, clinical laboratory geneticists should apply their professional judgment to the specific circumstances presented by the patient or specimen. Clinical laboratory scientists and geneticists are encouraged to document in the patient's record the rationale for the use of a particular procedure or test, whether or not it is in conformance with these Standards and Guidelines. They also are advised to take notice of the date any particular guideline was adopted, and to consider other relevant medical and scientific information that becomes available after that date. It also would be prudent to consider whether intellectual property interests may restrict the performance of certain tests and other procedures.Biotinidase deficiency is an autosomal recessively inherited disorder of biotin recycling that is associated with neurologic and cutaneous consequences if untreated. Fortunately, the clinical features of the disorder can be ameliorated or prevented by administering pharmacological doses of the vitamin biotin. Newborn screening and confirmatory diagnosis of biotinidase deficiency encompasses both enzymatic and molecular testing approaches. These guidelines were developed to define and standardize laboratory procedures for enzymatic biotinidase testing, to delineate situations for which follow-up molecular testing is warranted, and to characterize variables that can influence test performance and interpretation of results.
Similar articles
-
Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics.Genet Med. 2017 Feb;19(2):256-263. doi: 10.1038/gim.2016.203. Epub 2017 Jan 5. Genet Med. 2017. PMID: 28055022
-
Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG).Genet Med. 2018 Jan;20(1):3-11. doi: 10.1038/gim.2017.172. Epub 2017 Oct 26. Genet Med. 2018. PMID: 29261178
-
Technical standards and guidelines for the diagnosis of biotinidase deficiency.Genet Med. 2010 Jul;12(7):464-70. doi: 10.1097/GIM.0b013e3181e4cc0f. Genet Med. 2010. PMID: 20539236
-
Biotinidase deficiency: "if you have to have an inherited metabolic disease, this is the one to have".Genet Med. 2012 Jun;14(6):565-75. doi: 10.1038/gim.2011.6. Epub 2012 Jan 5. Genet Med. 2012. PMID: 22241090 Review.
-
Biotinidase deficiency and our champagne legacy.Gene. 2016 Sep 10;589(2):142-50. doi: 10.1016/j.gene.2015.10.010. Epub 2015 Oct 9. Gene. 2016. PMID: 26456103 Review.
Cited by
-
Newborn Screening for Biotinidase Deficiency. The Experience of a Regional Center in Italy.Front Pediatr. 2021 May 31;9:661416. doi: 10.3389/fped.2021.661416. eCollection 2021. Front Pediatr. 2021. PMID: 34136440 Free PMC article.
-
Inborn Errors of Metabolism in Pediatric Epilepsy.J Pediatr Pharmacol Ther. 2019 Sep-Oct;24(5):398-405. doi: 10.5863/1551-6776-24.5.398. J Pediatr Pharmacol Ther. 2019. PMID: 31598103 Free PMC article. Review.
-
Optimizing Biotinidase Activity Assays: Insights From Clinical and Laboratory Evaluation From a Low-Middle Income Country.Cureus. 2025 Feb 4;17(2):e78529. doi: 10.7759/cureus.78529. eCollection 2025 Feb. Cureus. 2025. PMID: 40062096 Free PMC article.
-
Beyond the homozygous paradigm: symptomatic partial biotinidase deficiency in a heterozygous child-first case report from Nepal.BMC Pediatr. 2025 Jun 4;25(1):450. doi: 10.1186/s12887-025-05822-2. BMC Pediatr. 2025. PMID: 40468249 Free PMC article.
-
1H-Nuclear Magnetic Resonance Analysis of Urine as Diagnostic Tool for Organic Acidemias and Aminoacidopathies.Metabolites. 2021 Dec 20;11(12):891. doi: 10.3390/metabo11120891. Metabolites. 2021. PMID: 34940649 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical